ACS Appl Mater Interfaces. 2018 Mar 14;10(10):9094-9103. doi: 10.1021/acsami.7b16096. Epub 2018 Mar 5.
Protein corona is immediately established on the surface of nanoparticles upon their introduction into biological milieu. Several studies have shown that the targeting efficiency of ligand-modified nanoparticles is attenuated or abolished owing to the protein adsorption. Here, transferrin receptor-targeting ligands, including LT7 (CHAIYPRH), DT7 (hrpyiahc, all d-form amino acids), and transferrin, were used to identify the influence of the ligand size and conformation on protein corona formation. The results showed that the targeting capacity of ligand-modified nanoparticles was lost after incubation with plasma in vitro, whereas it was partially retained after in vivo corona formation. Results from sodium dodecyl sulfate polyacrylamide gel electrophoresis and liquid chromatography-mass spectrometry revealed the difference in the composition of in vitro and in vivo corona, wherein the ligand size and conformation played a critical role. Differences were observed in cellular internalization and exocytosis profiles on the basis of the ligand and corona source.
蛋白质冠在纳米粒子被引入生物环境后立即在其表面形成。有几项研究表明,由于蛋白质吸附,配体修饰的纳米粒子的靶向效率降低或丧失。在这里,转铁蛋白受体靶向配体,包括 LT7(CHAIYPRH)、DT7(hrpyiahc,均为 d 型氨基酸)和转铁蛋白,被用于确定配体大小和构象对蛋白质冠形成的影响。结果表明,修饰配体的纳米粒子的靶向能力在与血浆体外孵育后丧失,而在体内形成冠后部分保留。十二烷基硫酸钠聚丙烯酰胺凝胶电泳和液相色谱-质谱的结果表明,体外和体内冠的组成存在差异,其中配体大小和构象起着关键作用。基于配体和冠的来源,观察到细胞内化和胞吐作用谱的差异。
ACS Appl Mater Interfaces. 2018-3-5
J Control Release. 2021-5-10
ACS Biomater Sci Eng. 2021-12-13
Pharmaceutics. 2024-12-30
Drug Deliv Transl Res. 2023-11
Int J Mol Sci. 2022-11-29
Int J Pharm X. 2022-10-21